Saturday 17 October 2026
Export VEEV’s income statement to Excel — free account
Veeva Systems Inc.
VEEV Healthcare Health Information Services
Veeva Systems Inc.’s revenue for fiscal 2026 (year ended January 2026) was $3.2 billion, up 16.3% from fiscal 2025. In the quarter to July 2026, revenue grew 17.6%, EPS grew 36.6% and free cash flow was flat, each against the same quarter a year earlier. Member of the S&P 500; revenue growth for ten consecutive years, operating cash flow growth for ten.
310.30
2.73
−0.87%
Follow VEEV
| Jul '26 | Apr '26 | Jan '26 | Oct '25 | Older periods | |
|---|---|---|---|---|---|
Piotroski F-Score |
5 | 5 | 7 | 7 |
+8 more TTM periods Free account |
| 14.42% | 13.93% | 13.93% | 13.72% | ||
| 11.90% | 11.15% | 11.14% | 11.83% | ||
ROIC |
343.12% | 0.00% | 87.58% | 133.10% | |
Return on Tangible Assets |
15.45% | 14.63% | 14.13% | 13.80% | |
Average Days of Receivables |
59.70 | 69.03 | 149.68 | 44.05 | |
Free Cash Flow per Share |
10.09 | 10.04 | 8.47 | 8.24 | |
Free Cash Flow |
1,638.77 | 1,640.21 | 1,386.09 | 1,351.10 | |
Capital Expenditures |
(26.69) | (24.97) | (29.13) | (26.82) | |
| Other line items | |||||
Cash ROIC |
11.17% | 11.22% | 10.06% | 9.88% | |
Accounts Receivable Turnover |
6.66 | 5.68 | 2.70 | 9.15 | |
Accounts Payable Turnover |
24.90 | 21.24 | 22.97 | 23.24 | |
Inventory Turnover |
0.00 | 0.00 | 0.00 | 0.00 | |
Average Days of Payables |
15.17 | 17.90 | 17.57 | 15.91 | |
Days of Inventory on Hand |
0.00 | 0.00 | 0.00 | 0.00 | |
Tax Rate |
(0.24) | (0.24) | (0.24) | (0.23) | |
Research and Development Expense of Revenue |
23.77% | 23.85% | 24.02% | 24.35% | |
Selling, General and Administrative Expense of Revenue |
21.27% | 22.37% | 22.83% | 23.43% | |
Share Based Compensation of Revenue |
14.30% | 14.45% | 14.79% | 15.25% | |
Operating CF/Net income |
1.64 | 1.77 | 1.56 | 1.60 | |
Depreciation/Fixed assets |
0.64 | 0.65 | 0.64 | 0.68 | |
Capex/Depreciation |
(0.53) | (0.52) | (0.65) | (0.59) | |
Revenue per Share |
21.30 | 20.32 | 19.52 | 18.78 | |
Operating CF per Share |
10.26 | 10.19 | 8.65 | 8.40 | |
Capex per Share |
(0.16) | (0.15) | (0.18) | (0.16) | |
Capex to Sales |
0.01 | 0.01 | 0.01 | 0.01 |
Columns are period end dates